Skip to main content
Back to Khosla Ventures

Khosla Ventures's Biotechnology Portfolio

Browse 10 Biotechnology companies funded by Khosla Ventures. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
10
Total Funding in Biotechnology
$552.1M

Biotechnology Portfolio Companies (10)

Export
Artificial Intelligence (AI)Biotechnology

Cellular Intelligence develops AI-driven foundation models and platforms to predict and control cell behavior for regenerative medicine.

Boston, United States
May 2026
$47.0M
Corporate Round

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalNeuroscience

Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.

Alameda, United States
March 2026
$230.0M
Series C

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPharmaceutical

Numerion Labs develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

San Francisco, United States
March 2026
$19.8M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

San Francisco, United States
October 2025
$25.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsHealth Care

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

South San Francisco, United States
October 2025
$45.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

BioinformaticsBiotechnologyGenetics

Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.

Boston, United States
October 2025
$31.0M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

South San Francisco, United States
August 2025
$23.7M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLifestyleMedical

Vivodyne accelerates drug discovery using lab-grown human tissues, robotics, and AI to generate accurate preclinical test data.

San Francisco, United States
May 2025
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyFertilityHealth Care

Overture Life is a biotechnology company that develops automated technologies for assisted reproductive procedures.

Alcobendas, Spain
April 2025
$20.6M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyManufacturing

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

Oakland, United States
March 2025
$70.0M
Series B

Founder Contacts

19,000+ verified contacts

Explore Khosla Ventures's Full Portfolio

View all companies funded by Khosla Ventures across every industry and funding stage.

View Full Khosla Ventures Portfolio